These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19950708)

  • 21. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factors influencing the long-term survival in pancreatic carcinoma patients after radical resection].
    Zhang WJ; Han SL; Jiang FZ; Zhu HL; Ye BL; Ke QH; Fang Y
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):870-2. PubMed ID: 19173836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
    Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
    Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?
    Amano H; Miura F; Toyota N; Wada K; Katoh K; Hayano K; Kadowaki S; Shibuya M; Maeno S; Eguchi T; Takada T; Asano T
    J Hepatobiliary Pancreat Surg; 2009; 16(6):850-7. PubMed ID: 19844653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
    Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure.
    Takada T; Yasuda H; Amano H; Yoshida M; Ando H
    Hepatogastroenterology; 1997; 44(18):1536-40. PubMed ID: 9427018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T
    Hepatogastroenterology; 2004; 51(59):1500-3. PubMed ID: 15362786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
    Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
    Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic head carcinoma: clinical analysis of 189 cases.
    Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.
    Tajima Y; Kuroki T; Ohno T; Furui J; Tsuneoka N; Adachi T; Mishima T; Kosaka T; Haraguchi M; Kanematsu T
    Pancreas; 2008 Apr; 36(3):324-7. PubMed ID: 18362854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.